SVP & Chief Information Security Officer, GSK

Chinese drug makers strike a record US$136 billion in out-licensing deals in 2025

Abrysvo Or Arexvy Market Competition Analysis 2025: How Players Are Shaping Growth

U.S. FDA approves AKEEGA® as the first precision therapy for BRCA2-mutated metastatic castration-sensitive prostate cancer with 54% reduction in disease progression vs standard of care*

Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Projected to Witness a Growth

Principal Scientist, Discovery DMPK Bioanalytical

GSK is a global biopharma company dedicated to improving health through innovation in specialty medicines and vaccines. The Discovery DMPK bioanalyst will analyze molecules across GSK’s portfolio, utilizing mass spectrometry skills to support discovery programs and drive projects forward in a fast-paced laboratory environment.

Documentation Specialist

Board Member

Bioanalytical Services Market Projected to Reach US$ 11.61 Billion by 2035, Driven by Rising FDA Approvals and Clinical Trial Activity Says Astute Analytica

Eurofins: Weekly Report on Share Repurchases From 08th December to 12th December 2025

Eurofins Scientific SE: Director/PDMR Shareholding

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 November 2025

Discovery Bioanalytical Scientist

Eurofins Scientific is an international life sciences company providing analytical testing services across multiple industries. The Discovery Bioanalytical Scientist will prepare and analyze LC-MS samples, assist in developing bioanalytical methods, and document experimental procedures and results accurately.

Discovery Bioanalytical Scientist in united states (1000+)

Principal Scientist, Discovery DMPK Bioanalytical

Discovery Bioanalytical Scientist